International Journal of Travel Medicine and Global Health

International Journal of Travel Medicine and Global Health

Cardiovascular Disease Among International Travellers

Document Type : Review Article

Authors
1 Public Health Institute, Liverpool John Moores University, Liverpool, UK
2 School of Human and Health Sciences, University of Huddersfield, Huddersfield, UK
10.34172/ijtmgh.2021.18
Abstract
Introduction: Cardiovascular disease (CVD) is the leading cause of death among international travellers. This study aims to estimate the proportion of travellers diagnosed with CVD during international travel.
Methods: A narrative synthesis of peer-reviewed literature was conducted on CVD among international travellers. Healthcare databases and sources of grey literature were searched using pre-defined criteria between February and June 2019. Two reviewers screened all the identified studies against protocol and extracted data using a piloted form.
Results: Eight studies were eligible for final analysis. Four studies evaluated data from GeoSentinel Clinic databases. The number of study participants varied across studies from a minimum of 24 to a maximum of 63 076. Between 0.1% and 14% of international travellers were reported or diagnosed with CVD while travelling abroad. CVD was common in male travellers as compared with female travellers. There was a lack of information on pre-existing morbidity, smoking status, obesity in all included studies.
Conclusion: This review provides a first-time estimate of the proportion of international travellers with CVD while travelling overseas. Hence, preventive measures to minimize CVD risk such as sufficient exercises during long-distance flights, progressive acclimatization to altitude, wearing a face mask in polluted areas, maintaining a healthy lifestyle, and nutrition during travelling should be considered. CVD should be an important part of pre-travel health advice.
Keywords

Volume 9, Issue 3 - Serial Number 34
Summer 2021
Pages 107-112

  • Receive Date 11 November 2020
  • Revise Date 05 April 2021
  • Accept Date 06 April 2021